MSHP 2007 Clinical Symposium

8:00 - 8:30	Registration and Vendor Exhibits
8:30 - 10:00 1.5 Contact hours, 0.15 CEU UPN: 204-000-07-415-L01	Evidence-based Strategies for Improving Patient Outcomes: Focus on Antithrombotic Therapy in the Management of Acute Coronary Syndrome Paul P. Dobesh, PharmD, FCCP, BCPS Associate Professor of Pharmacy Practice College of Pharmacy University of Nebraska Medical Center Omaha, Nebraska Objectives: 1. Describe the clinical and economic burden and pathophysiology of ACS. 2. Discuss pharmacological treatment strategies and expected outcomes for patients with acute coronary syndrome as recommended by the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (STEMI). 3. Summarize the latest clinical research, and its potential impact on therapy, regarding antithrombotic therapy in the management of patients with ST segment elevation myocardial infarction (STEMI), including a comparison of the safety and efficacy of unfractionated heparin, low-molecular-weight heparin, factor Xa inhibitor therapy, and thrombin inhibitors. 4. Describe the role of evidence-based clinical guidelines and performance measurement in improving the quality of patient care and the potential role of pharmacists in their implementation. This presentation is planned by ASHP Advantage and supported by an educational grant from Sanofi-Aventis U.S.
10:00 – 10:30	Break & Vendor Exhibits
10:30 - 12:00 1.5 Contact hours, 0.15 CEU UPN: 204-000-07-417-L01	Evidence-based Strategies for Improving Patient Outcomes: Antithrombotic Therapy in the Prevention and Management of Venous Thromboembolism Carla E. Staresinic, PharmD, CACP Manager, Anticoagulation Clinic William S. Middleton Memorial VA Hospital Clinical Instructor, University of Wisconsin Madison, Wisconsin Objectives: 1. Summarize current clinical guidelines and associated research regarding the assessment, prevention, and treatment of VTE in hospitalized patients. 2. Identify patients at risk for VTE and opportunities for its prevention. 3. List and discuss clinical considerations associated with the risk and prevention and management of VTE in special patient populations. 4. Describe the role of evidence-based clinical guidelines and performance measurement in improving the quality of patient care and the potential role of pharmacists in their implementation. 5. Outline a strategy for ensuring compliance with the JCAHO/NQF performance standards on VTE prevention. This presentation is planned by ASHP Advantage and supported by an educational grant from Sanofi-Aventis U.S.
12:15 - 1:15	Lunch Buffet and Vendor Exhibits
1:15 - 2:45 1.5 Contact hours, 0.15 CEU UPN: 060-999-07-023-L01	Erythropoiesis Stimulating Agents: Current Controversies Katherine Miller, PharmD, BCPS Central Maine Medical Center, Pharmacy Clinical Coordinator Ward Bennett Reimbursement Coordinator, New England Ortho Biotech Objectives: 1. Discuss clinical implications of recent literature related to erythropoiesis stimulating agents (ESAs) including risk/benefit ratio. 2. Discuss recommendations and recent statements relating to ESAs from FDA, NCCN, and ASCO. 3. Discuss recent changes in CMS reimbursements and implications for patient care.
2:45 - 4:00	Update on Pharmacy Schools in Maine John F. Cormier, M.S., PharmD Dean, School of Pharmacy University of New England Biddeford, Maine Rodney A. Larson, PhD, RPh Dean, School of Pharmacy Husson College Bangor, Maine

All participants will have the opportunity to evaluate the speaker and to identify future educational needs. Completion of signature sheets and evaluation forms at the conclusion of the program are required for issuance of statements of credit.
	The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of pharmacy education. Attendees must complete a Continuing Pharmacy Education Request online and may immediately print their official ASHP CE statements at the ASHP Advantage CE Processing Center at www.ashpadvantage.com. For complete program information, visit www.ashpadvantage.com/clot. In preparation for attending the live programs, registrants are encouraged to participate in a free online introductory course on each of the topics. These programs may be accessed directly at: ACS - http://symposia.ashp.org/acs-essentials/ VTE - http://symposia.ashp.org/vte-essentials/
Registration Fees:
Pharmacist Member: $55 Technician Member: $20	Pharmacist Non-Member: $75 (Includes 1-year membership fee) Technician Non-Member: $30 (Includes 1-year membership fee)
Online registration closes October 15. Contact Steve Townsend at 207-626-4836 to check on attendance availability Registration fees will be collected at the door.
LODGING: A 15% discount is available to participants for lodging at the Maple Hill Farm B&B. Space is limited, so make reservations early.


	The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. Attendance and completion of evaluation forms and self-assessment tools at the conclusion of the program are required for issuance of statement of credit, and will be mailed within four weeks.